BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30244128)

  • 1. Silencing of FTS increases radiosensitivity by blocking radiation-induced Notch1 activation and spheroid formation in cervical cancer cells.
    Prabakaran DS; Muthusami S; Sivaraman T; Yu JR; Park WY
    Int J Biol Macromol; 2019 Apr; 126():1318-1325. PubMed ID: 30244128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of Fused Toes Homolog (FTS) Increases Radiosensitivity to Carbon-Ion Through Downregulation of Notch Signaling in Cervical Cancer Cells.
    D S P; Chaturvedi PK; Shimokawa T; Kim KH; Park WY
    Front Oncol; 2021; 11():730607. PubMed ID: 34765546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fused Toes Homolog modulates radiation cytotoxicity in uterine cervical cancer cells.
    Anandharaj A; Cinghu S; Kim WD; Yu JR; Park WY
    Mol Biol Rep; 2011 Nov; 38(8):5361-70. PubMed ID: 21424602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1.
    Tyagi A; Vishnoi K; Mahata S; Verma G; Srivastava Y; Masaldan S; Roy BG; Bharti AC; Das BC
    Clin Cancer Res; 2016 Aug; 22(16):4170-84. PubMed ID: 26988248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTS (fused toes homolog) a novel oncoprotein involved in uterine cervical carcinogenesis and a potential diagnostic marker for cervical cancer.
    Cinghu S; Anandharaj A; Lee HC; Yu JR; Park WY
    J Cell Physiol; 2011 Jun; 226(6):1564-72. PubMed ID: 20945372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage.
    Subramanian PD; An Z; Yu JR; Park WY
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):753-62. PubMed ID: 27535835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTS is responsible for radiation-induced nuclear phosphorylation of EGFR and repair of DNA damage in cervical cancer cells.
    Muthusami S; Prabakaran DS; Yu JR; Park WY
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):203-10. PubMed ID: 25151576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGCG suppresses Fused Toes Homolog protein through p53 in cervical cancer cells.
    Muthusami S; Prabakaran DS; An Z; Yu JR; Park WY
    Mol Biol Rep; 2013 Oct; 40(10):5587-96. PubMed ID: 24065519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Notch1/Hes1 signaling pathway improves radiosensitivity of colorectal cancer cells.
    Zhang H; Jiang H; Chen L; Liu J; Hu X; Zhang H
    Eur J Pharmacol; 2018 Jan; 818():364-370. PubMed ID: 29126793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
    Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
    Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway.
    Jin L; Vu T; Yuan G; Datta PK
    Cancer Res; 2017 Oct; 77(20):5464-5478. PubMed ID: 28827371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF-induced expression of Fused Toes Homolog (FTS) facilitates epithelial-mesenchymal transition and promotes cell migration in ME180 cervical cancer cells.
    Muthusami S; Prabakaran DS; Yu JR; Park WY
    Cancer Lett; 2014 Sep; 351(2):252-9. PubMed ID: 24971934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma.
    Panaccione A; Chang MT; Carbone BE; Guo Y; Moskaluk CA; Virk RK; Chiriboga L; Prasad ML; Judson B; Mehra S; Yarbrough WG; Ivanov SV
    Clin Cancer Res; 2016 Apr; 22(8):2083-95. PubMed ID: 27084744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
    Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
    Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
    Bi YL; Min M; Shen W; Liu Y
    Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalein suppresses the proliferation of human cervical cancer cells via Notch 1/Hes signaling pathway.
    Lian H; Hui Y; Xiaoping T; Wei T; Jiyi X; Xiaolan Y
    J Cancer Res Ther; 2019; 15(6):1216-1220. PubMed ID: 31898650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PM2.5 induces EMT and promotes CSC properties by activating Notch pathway in vivo and vitro.
    Wang Y; Zhong Y; Hou T; Liao J; Zhang C; Sun C; Wang G
    Ecotoxicol Environ Saf; 2019 Aug; 178():159-167. PubMed ID: 31002970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/ Progenitor Cells.
    Shen Y; Chen H; Zhang J; Chen Y; Wang M; Ma J; Hong L; Liu N; Fan Q; Lu X; Tian Y; Wang A; Dong J; Lan Q; Huang Q
    PLoS One; 2015; 10(11):e0142594. PubMed ID: 26599017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.
    López J; Poitevin A; Mendoza-Martínez V; Pérez-Plasencia C; García-Carrancá A
    BMC Cancer; 2012 Jan; 12():48. PubMed ID: 22284662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.